Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks

Philip E. Castle, Barbara Fetterman, Nancy Poitras, Thomas Lorey, Ruth Shaber, Walter Kinney

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

OBJECTIVE: To quantify the age-specific and reproductive organ-specific cancer risk after an atypical glandular cell (AGC) cytologic interpretation in large clinic-based sample in which routine high-risk human papillomavirus (HPV) testing is conducted. METHODS: To estimate the absolute risk of cervical precancer, cervical cancer, and endometrial cancer in women with AGC cytology, we conducted a cross-sectional study of women with AGC cytology (n=1,422) in a large health maintenance organization that introduced high-risk HPV DNA testing into cervical cancer screening in 2003. Risks and binomial exact 95% confidence intervals (CIs) of cervical intraepithelial neoplasia grade 2 or more severe (CIN 2 or worse) and endometrial cancer were calculated. Results: A total of 238 women with AGC cytology (16.7%, 95% CI 14.8-18.8%) were diagnosed with CIN 2 or worse, endometrial cancer, or other cancers. Among women aged 50 years or older, 420 high-risk HPV-negative women were at a 10.5% (95% CI 7.7-13.8%) risk of endometrial cancer, and 77 high-risk HPV-positive women were at a 10.4% (95% CI 4.6-19.4%) risk of cervical cancer and 0% (95% CI 0.0-4.7%) risk of endometrial cancer. Conclusion: High-risk HPV testing may distinguish between risk of endometrial cancer and cervical cancer in women with AGC cervical cytology, particularly in women aged 50 years or older.

Original languageEnglish (US)
Pages (from-to)243-248
Number of pages6
JournalObstetrics and Gynecology
Volume115
Issue number2 PART 1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Endometrial Neoplasms
Uterine Cervical Neoplasms
Cell Biology
Confidence Intervals
Cervical Intraepithelial Neoplasia
Health Maintenance Organizations
Early Detection of Cancer
Neoplasms
Cross-Sectional Studies

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks. / Castle, Philip E.; Fetterman, Barbara; Poitras, Nancy; Lorey, Thomas; Shaber, Ruth; Kinney, Walter.

In: Obstetrics and Gynecology, Vol. 115, No. 2 PART 1, 02.2010, p. 243-248.

Research output: Contribution to journalArticle

Castle, Philip E. ; Fetterman, Barbara ; Poitras, Nancy ; Lorey, Thomas ; Shaber, Ruth ; Kinney, Walter. / Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks. In: Obstetrics and Gynecology. 2010 ; Vol. 115, No. 2 PART 1. pp. 243-248.
@article{ce38e1fb6b074939ae5fed979cf46224,
title = "Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks",
abstract = "OBJECTIVE: To quantify the age-specific and reproductive organ-specific cancer risk after an atypical glandular cell (AGC) cytologic interpretation in large clinic-based sample in which routine high-risk human papillomavirus (HPV) testing is conducted. METHODS: To estimate the absolute risk of cervical precancer, cervical cancer, and endometrial cancer in women with AGC cytology, we conducted a cross-sectional study of women with AGC cytology (n=1,422) in a large health maintenance organization that introduced high-risk HPV DNA testing into cervical cancer screening in 2003. Risks and binomial exact 95{\%} confidence intervals (CIs) of cervical intraepithelial neoplasia grade 2 or more severe (CIN 2 or worse) and endometrial cancer were calculated. Results: A total of 238 women with AGC cytology (16.7{\%}, 95{\%} CI 14.8-18.8{\%}) were diagnosed with CIN 2 or worse, endometrial cancer, or other cancers. Among women aged 50 years or older, 420 high-risk HPV-negative women were at a 10.5{\%} (95{\%} CI 7.7-13.8{\%}) risk of endometrial cancer, and 77 high-risk HPV-positive women were at a 10.4{\%} (95{\%} CI 4.6-19.4{\%}) risk of cervical cancer and 0{\%} (95{\%} CI 0.0-4.7{\%}) risk of endometrial cancer. Conclusion: High-risk HPV testing may distinguish between risk of endometrial cancer and cervical cancer in women with AGC cervical cytology, particularly in women aged 50 years or older.",
author = "Castle, {Philip E.} and Barbara Fetterman and Nancy Poitras and Thomas Lorey and Ruth Shaber and Walter Kinney",
year = "2010",
month = "2",
doi = "10.1097/AOG.0b013e3181c799a3",
language = "English (US)",
volume = "115",
pages = "243--248",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2 PART 1",

}

TY - JOUR

T1 - Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks

AU - Castle, Philip E.

AU - Fetterman, Barbara

AU - Poitras, Nancy

AU - Lorey, Thomas

AU - Shaber, Ruth

AU - Kinney, Walter

PY - 2010/2

Y1 - 2010/2

N2 - OBJECTIVE: To quantify the age-specific and reproductive organ-specific cancer risk after an atypical glandular cell (AGC) cytologic interpretation in large clinic-based sample in which routine high-risk human papillomavirus (HPV) testing is conducted. METHODS: To estimate the absolute risk of cervical precancer, cervical cancer, and endometrial cancer in women with AGC cytology, we conducted a cross-sectional study of women with AGC cytology (n=1,422) in a large health maintenance organization that introduced high-risk HPV DNA testing into cervical cancer screening in 2003. Risks and binomial exact 95% confidence intervals (CIs) of cervical intraepithelial neoplasia grade 2 or more severe (CIN 2 or worse) and endometrial cancer were calculated. Results: A total of 238 women with AGC cytology (16.7%, 95% CI 14.8-18.8%) were diagnosed with CIN 2 or worse, endometrial cancer, or other cancers. Among women aged 50 years or older, 420 high-risk HPV-negative women were at a 10.5% (95% CI 7.7-13.8%) risk of endometrial cancer, and 77 high-risk HPV-positive women were at a 10.4% (95% CI 4.6-19.4%) risk of cervical cancer and 0% (95% CI 0.0-4.7%) risk of endometrial cancer. Conclusion: High-risk HPV testing may distinguish between risk of endometrial cancer and cervical cancer in women with AGC cervical cytology, particularly in women aged 50 years or older.

AB - OBJECTIVE: To quantify the age-specific and reproductive organ-specific cancer risk after an atypical glandular cell (AGC) cytologic interpretation in large clinic-based sample in which routine high-risk human papillomavirus (HPV) testing is conducted. METHODS: To estimate the absolute risk of cervical precancer, cervical cancer, and endometrial cancer in women with AGC cytology, we conducted a cross-sectional study of women with AGC cytology (n=1,422) in a large health maintenance organization that introduced high-risk HPV DNA testing into cervical cancer screening in 2003. Risks and binomial exact 95% confidence intervals (CIs) of cervical intraepithelial neoplasia grade 2 or more severe (CIN 2 or worse) and endometrial cancer were calculated. Results: A total of 238 women with AGC cytology (16.7%, 95% CI 14.8-18.8%) were diagnosed with CIN 2 or worse, endometrial cancer, or other cancers. Among women aged 50 years or older, 420 high-risk HPV-negative women were at a 10.5% (95% CI 7.7-13.8%) risk of endometrial cancer, and 77 high-risk HPV-positive women were at a 10.4% (95% CI 4.6-19.4%) risk of cervical cancer and 0% (95% CI 0.0-4.7%) risk of endometrial cancer. Conclusion: High-risk HPV testing may distinguish between risk of endometrial cancer and cervical cancer in women with AGC cervical cytology, particularly in women aged 50 years or older.

UR - http://www.scopus.com/inward/record.url?scp=76549106083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76549106083&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e3181c799a3

DO - 10.1097/AOG.0b013e3181c799a3

M3 - Article

C2 - 20093895

AN - SCOPUS:76549106083

VL - 115

SP - 243

EP - 248

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2 PART 1

ER -